Patents by Inventor Muhammed Ahmed Mesaik

Muhammed Ahmed Mesaik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Myrtocomuloacetalone 1 as an anti-inflammatory agent
    Patent number: 9701690
    Abstract: A novel compound Myrtocomuloacetalone 1 (MCA-1) exhibiting potent anti-inflammatory properties by inhibiting production of reactive oxygen species, including nitric oxide, superoxide, and hydrogen peroxide that effectively suppresses proliferation of T-cells and also reduces intracellular oxidative stress and inhibits NF kappa B activation.
    Type: Grant
    Filed: March 19, 2014
    Date of Patent: July 11, 2017
    Inventors: Muhammed Ahmed Mesaik, Samreen Soomro, Farzana Shaheen, Noureen Khan, Zaheerul haq Qasmi, Sobia Ahsan Halim, M. Iqbal Choudhary
  • MYRTOCOMULOACETALONE 1 AS AN ANTI INFLAMMATORY AGENT
    Publication number: 20150266889
    Abstract: A novel compound Myrtocomuloacetalone 1 (MCA-1) exhibiting potent anti-inflammatory properties by inhibiting production of reactive oxygen species, including nitric oxide, superoxide, and hydrogen peroxide that effectively suppresses proliferation of T-cells and also reduces intracellular oxidative stress and inhibits NF kappa B activation.
    Type: Application
    Filed: March 19, 2014
    Publication date: September 24, 2015
    Inventors: Muhammed Ahmed Mesaik, Samreen Soomro, Farzana Shaheen, Noureen Khan, Zaheerul haq Qasmi, Sobia Ahsan Halim, M. Ipbal Choudhary
  • PATULETIN A POTENT ANTI-TNF-a AND ANTI-ARTHRITIC COMPOUND FROM TAGETES PATULA
    Publication number: 20150025131
    Abstract: Patuletin, a flavonoid isolated from Tagetes patula, was discovered to be a potent inhibitor of TNF-? production and thus useful in treating diseases related to TNF-? levels in the body.
    Type: Application
    Filed: July 17, 2013
    Publication date: January 22, 2015
    Inventors: Muhammed Ahmed Mesaik, Almas Jabeen, Shaheen Faizi, Shabana Usman Simjee, Samina Bano, Lubna
  • Antiinflammatory compound
    Patent number: 8329678
    Abstract: Azadirachta indica cell suspension culture was used for the biotransformation of dianabol to yield a metabolite 17?-hydroxy-17?-methyl-5?-androstan-3-one, which can also be synthesized, as a potent antiinflammatory agent.
    Type: Grant
    Filed: July 17, 2011
    Date of Patent: December 11, 2012
    Inventors: Saif Ullah, Saifullah Khan, Muhammed Ahmed Mesaik, Zaheerul Haq, Almas Jabeen, Sobia Ahsan Halim, Muhammad Iqbal Choudhary